Cytosorbents Corporation

CTSO

Find Out if You Qualify for a Financial Reward by filling out the form below.

Cytosorbents Corporation Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On December 28, 2023, Cytosorbents issued a press release announcing that its pivotal trial investigating the ability of its device candidate, DrugSorb®-ATR, to reduce perioperative bleeding in patients on ticagrelor (Brilinta®, Brilique® – AstraZeneca) undergoing cardiothoracic surgery before completing the recommended washout period, “did not meet the primary effectiveness endpoint in the overall patient population that underwent different types of cardiac surgeries.”

On this news, Cytosorbents’ stock price fell $0.545 per share, or 33.44%, to close at $1.085 per share on December 28, 2023.

Active Cases

Ticker Symbol Company Name Join Deadline Join
OFIX Orthofix Medical Inc. October 21, 2024 Join
DXCM DexCom, Inc. October 21, 2024 Join
SPIR Spire Global, Inc. October 21, 2024 Join
STM STMicroelectronics N.V. October 22, 2024 Join
DAVA Endava plc October 25, 2024 Join
MEI Methode Electronics, Inc. October 25, 2024 Join
SAGE Sage Therapeutics, Inc. October 28, 2024 Join
VERV Verve Therapeutics, Inc. October 28, 2024 Join
SBUX Starbucks Corporation October 28, 2024 Join
OM Outset Medical, Inc. October 28, 2024 Join
SMCI Super Micro Computer, Inc. October 29, 2024 Join
ZI ZoomInfo Technologies Inc. November 04, 2024 Join
WBTN WEBTOON Entertainment Inc. November 04, 2024 Join
GTLB GitLab Inc. November 04, 2024 Join
GTLB GitLab Inc. November 04, 2024 Join
AGEN Agenus Inc. November 05, 2024 Join
NFE New Fortress Energy Inc. November 18, 2024 Join
MGX Metagenomi, Inc. November 25, 2024 Join
BMBL Bumble Inc. November 25, 2024 Join
UPS United Parcel Service, Inc. December 09, 2024 Join
EW Edwards Lifesciences Corporation December 13, 2024 Join